Krayon Lifesciences India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.80 M
as on 18-12-2024
- Revenue -6.81%
(FY 2022)
- Profit -3610.59%
(FY 2022)
- Ebitda -541.93%
(FY 2022)
- Net Worth -523.47%
(FY 2022)
- Total Assets -48.33%
(FY 2022)
About Krayon Lifesciences India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sapan Shah, Shobhanaben Shah, and Kairav Shah serve as directors at the Company.
- CIN/LLPIN
U24299GJ2017PTC100070
- Company No.
100070
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Krayon Lifesciences India Private Limited offer?
Krayon Lifesciences India Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Antifungal Injection, Tablet & Syrup, Common Disease Medicines, Antihistamines, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Allopathic Cough Syrup, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Krayon Lifesciences India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sapan Shah  | Director | 08-Dec-2017 | Current |
| Shobhanaben Shah | Director | 08-Dec-2017 | Current |
| Kairav Shah | Director | 09-Nov-2023 | Current |
Financial Performance of Krayon Lifesciences India.
Krayon Lifesciences India Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 6.81% decrease. The company also saw a substantial fall in profitability, with a 3610.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 523.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krayon Lifesciences India?
In 2020, Krayon Lifesciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jun 2020 | ₹0.30 M | Satisfied |
Others Creation Date: 06 Mar 2019 | ₹1.50 M | Satisfied |
How Many Employees Work at Krayon Lifesciences India?
Unlock and access historical data on people associated with Krayon Lifesciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krayon Lifesciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krayon Lifesciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
